Clinical Trials on SARS-CoV 2 in Australia

Total 470 results

Medical University of Vienna

Unknown

Study to Develop a Kinetic Model for FDG and Me4FDG in Kidneys of Type 2 Diabetic Patients

Type2 Diabetes Mellitus

Austria
Medical University of Vienna
National Bank of Austria

Unknown

Tele-Diab: Electronic Diary for Patients With Type 2 Diabetes Mellitus (Tele-Diab)

Insulin Resistance | Diabetes Mellitus Type 2

Austria
Medical University of Vienna

Unknown

Influence of DPP-4 on Inflammatory Parameters in Diabetics: Gender Aspects

Type 2 Diabetes Mellitus | Endothelial Dysfunction | Cardiovascular Risk

Austria
Menzies School of Health Research

Withdrawn

Medication in Early Diabetes (MED) Study

Diabetes Mellitus, Type 2

Australia
Medical University of Vienna

Completed

The Impact of Free Fatty Acid (FFA-) Suppression on Myocardial Lipids and Function in Patients With Type 2 Diabetes (HYPOTESIS)

Type 2 Diabetes

Austria
Medical University of Graz

Completed

EndoBarrier in Obese Subjects With Type 2 Diabetes Mellitus

Obesity | Type 2 Diabetes

Austria
Meridian Bioscience, Inc.

Completed

Detection of Cytomegalovirus Virus in Neonates (CMV)

CMV

United States, Australia, Canada, Italy
Paracelsus Medical University

Completed

Exercise Training Improves Coronary Endothelial Dysfunction in Diabetes Mellitus Type 2 and Coronary Artery Disease

Coronary Artery Disease | Type 2 Diabetes Mellitus

Austria
GlaxoSmithKline

Terminated

Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers

Diabetes Mellitus, Type 2

Australia
Sanofi

Completed

REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic Agents (REASSURE)

Diabetes Mellitus, Type 2

Australia
AstraZeneca
Eli Lilly and Company

Completed

Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy

Type 2 Diabetes Mellitus

Italy, Poland, Hungary, Mexico, Greece, Australia
University of Sydney

Unknown

Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation (R3ACT)

CMV Infection | EBV | Adenovirus

Australia
DiObex

Terminated

Open Label Safety & Pharmacodynamic Study 24Wk w/DIO-902 Combo w/Metformin & Atorvastatin in T2DM Patients

Type 2 Diabetes

Australia, United States, New Zealand
Medical University of Graz

Completed

Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial Lipids (HUCKEPACK2)

Type 2 Diabetes

Austria
Bayside Health

Completed

Dietary Advanced Glycation End-products and Insulin Resistance in Overweight and Obese Humans

Obesity | Insulin Resistance | Type 2 Diabetes

Australia
Medical University of Graz

Completed

The Influence of Fatty-Acids on Systemic and Subcutaneous Cytokines (TNF4)

Obesity | Type 2 Diabetes Mellitus

Austria
Baker Heart Research Institute

Unknown

The Effects of Weight Loss on Neuroadrenergic Function

Obesity | Metabolic Syndrome | Type 2 Diabetes

Australia
Bristol-Myers Squibb

Completed

Safety Study of BMS-816336 in Healthy Male Subjects

Dyslipidemia | Diabetes Mellitus, Non-Insulin-Dependent

Australia
DiObex

Terminated

A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes

Type 2 Diabetes

Australia, United States, New Zealand
Landeskrankenanstalten-Betriebsgesellschaft
European Commission

Completed

Medium-term Health Coaching and Life-long Monitoring in Diabetes Mellitus (RenewingHealth)

Diabetes Mellitus Type 2

Austria
Medical University of Vienna
St. Vincent Hospital, Vienna

Completed

MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis

Diabetes Type 2 | Postmenopausal Osteoporosis

Austria
Melbourne Health
Peter MacCallum Cancer Centre, Australia; Western Sydney Local Health District and other collaborators

Enrolling by invitation

Cytomegalovirus (CMV) Reactivation in Allogeneic HSCT Recipient (CReSCT)

Cytomegalovirus Infections | Immune Suppression | Haematological Malignancy | Organ or Tissue Transplant; Complications

Australia
Medical University of Vienna

Completed

Evaluation of Intestinal Brush Border Enzyme Function in Critically Ill Patients

Critical Illness | Septic Shock | SIRS

Austria
D3 Bio (Wuxi) Co., Ltd

Recruiting

A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid Tumors

HER-2 Positive Advanced Solid Tumors

Australia, United States, China
Garvan Institute of Medical Research

Completed

Effects of Medical and Surgical Weight Loss on Metabolism (BOS)

Obesity | Type 2 Diabetes

Australia
Sanofi

Completed

Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin Treatment

Type 2 Diabetes Mellitus

France, Poland, Germany, Italy, Netherlands, Belgium, Denmark, Chile, South Africa, Australia, Argentina
Bayside Health
National Institutes of Health (NIH); Monash Medical Centre

Unknown

Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)

HIV Infections | HIV-hepatitis Co-infection

Australia
Starpharma Pty Ltd
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing.

HIV Infections | HSV-2 Genital Herpes

Australia
Novartis Pharmaceuticals

Completed

A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast Cancer

Metastatic Breast Cancer | HER-2 Positive Breast Cancer

Belgium, Netherlands, Australia, Italy, United States
Medtronic Diabetes

Completed

User Evaluation of the MiniMed 640G Insulin Pump

Type 1 Diabetes | Type 2 Diabetes

United Kingdom, Australia
Novo Nordisk A/S

Completed

Attitudes and Unmet Needs Among Type 2 Diabetes Patients

Type 2 Diabetes

Korea, Republic of, Mexico, India, United Kingdom, Australia, France, Saudi Arabia
Medical University of Vienna

Unknown

Effects of SGLT-2 Inhibition on Hepatic Glucose and Energy Metabolism

Type 2 Diabetes | Metabolically Healthy Controls

Austria
MetaCure Limited

Completed

Evaluation of the Tantalus System in Type 2 Diabetic Subjects

Obesity | Type 2 Diabetes

Austria
Neurotech Pharmaceuticals
The Lowy Medical Research Institute Limited

Completed

Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2

Macular Telangiectasia Type 2

United States, Australia
Medical University of Vienna
AstraZeneca

Completed

Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus. (EXENDA)

Type2 Diabetes | Steatosis, Liver

Austria
BeiGene

Recruiting

Study of BGB-A425 and LBL-007 in Combination With Tislelizumab in Advanced Solid Tumors

Locally Advanced or Metastatic Solid Tumors for Phase 1,Dose Escalation and Phase 2 Safety Lead-in, HNSCC, NSCLC and RCC Participants for Phase 2

Australia, United States, Spain, France, Italy, Korea, Republic of, Poland
Hoffmann-La Roche

Completed

European, Open-label, Prospective, Multinational, Multicenter Study in Adult Subjects With Type 1 or Type 2 Diabetes Previously on MDI or CSII Therapy. Subjects Home Setting is Considered Routine Practice.

Type 2 Diabetes, Type 1 Diabetes

Austria, United Kingdom
The University of New South Wales
National Health and Medical Research Council, Australia; Novo Nordisk A/S; Sydney...

Completed

Rosiglitazone and Insulin in T1DM Adolescents

Type 1 Diabetes | Puberty: >Tanner 2 Breast Development or Testis >4ml

Australia
St. Pölten University of Applied Sciences
Karl Landsteiner University of Health Sciences; Austrian Health Insurance Fund

Active, not recruiting

Improving Glycaemic Control in Patients With Type 2 Diabetes Mellitus Through Peer Support Instant Messaging (DiabPeerS)

Diabetes Mellitus, Type 2 | Peer Support | Instant Messaging Service

Austria
Medical University of Graz

Completed

A Trial to Investigate Efficacy and Usability of Published Best Practice to Control Glycaemia

Diabetes Mellitus, Type 2

Austria
Arecor Limited

Completed

AT278, NovoRapid® and Humulin® R (U500) in Glucose Clamp Study

Diabetes Mellitus, Type 2

Austria
University Hospital Tuebingen
Medical University of Vienna; University of Bern; CenTrial GmbH

Terminated

Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine

Obesity | Diabetes

Austria, Germany, Switzerland
Melbourne Health

Completed

Vascular Reactivity in Kidney Disease Patients

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Kidney Failure, Chronic

Australia
Novo Nordisk A/S

Completed

Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes (INTENSIV)

Diabetes Mellitus, Type 2 | Diabetes

Austria
Novo Nordisk A/S

Completed

A Research Study of How Overdosing of a New Once Weekly Medicine NNC0148-0287 C (Insulin 287) Influences the Blood Sugar Level in People With Type 2 Diabetes

Diabetes Mellitus, Type 2

Austria
Hoffmann-La Roche

Completed

A Study of RO5093151 and RO5027838 in Patients With Type 2 Diabetes Mellitus on a Stable Dose of Metformin

Diabetes Mellitus Type 2

Austria, Germany, United States
Novo Nordisk A/S

Recruiting

A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged Fasting

Diabetes Mellitus, Type 2

Austria
Novo Nordisk A/S

Completed

A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Insulin Icodec in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2

Austria
Novo Nordisk A/S

Completed

A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2 | Diabetes

Austria
Medical University of Vienna

Unknown

Viennese Registry on Patients With Chronic Critical Limb Ischemia

Chronic (> 2 Weeks) Critical Ischemia With Skin Defect in Lower Limbs

Austria

Clinical Trials on SARS-CoV 2 in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations